During the past decade, Tokyo Medical University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical University" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tokyo Medical University" are "Colorectal Neoplasms" (1 trials), "Lymphoma, B-Cell" (1 trials) and "Rectal Neoplasms" (1 trials). Many other conditions were trialed in "Tokyo Medical University" in a lesser frequency.

Most popular intervention types in "Tokyo Medical University" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5FU+l-leucovorin" (1 trials), "Mesorectal excision with lateral lymph node dissection" (1 trials), "Mesorectal excision without lateral lymph node excision" (1 trials), "Rituximab + Bi-weekly CHOP" (1 trials) and "Rituximab + Standard CHOP" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Medical University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Medical University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Tokyo Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Medical University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".